Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells

References

• Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Reviews Clin Oncology. 2017;14(10):611–629. Epub 2017/ 04/12. PubMed PMID: 28397828. .
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Marjanovic ND, Lee T, et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 2013;154(1):61–74. Epub 2013/07/06. PubMed PMID: 23827675; PubMed Central PMCID: PMCPmc4015106. .
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang Y. Cancer stem cells: models, mechanisms and implications for improved treatment. Cell Cycle (Georgetown, Tex). 2008;7(10):1360–1370. Epub 2008/ 04/18. PubMed PMID: 18418062. .
   PubMed Web of Science ®Google Scholar
• Chen X, Rycaj K, Liu X, et al. New insights into prostate cancer stem cells. Cell Cycle (Georgetown, Tex). 2013;12(4):579–586. Epub 2013/ 02/02. PubMed PMID: 23370446; PubMed Central PMCID: PMCPmc3594258. .
   PubMed Web of Science ®Google Scholar
• Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23(10):1124–1134. Epub 2017/10/07. PubMed PMID: 28985214. .
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Brueckmann I, Scheel C, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011;108(19):7950–7955. Epub 2011/04/19. PubMed PMID: 21498687; PubMed Central PMCID: PMCPmc3093533. .
   PubMed Web of Science ®Google Scholar
• Ning X, Du Y, Ben Q, et al. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Cell Cycle (Georgetown, Tex). 2016;15(3):403–412. Epub 2015/ 12/29. PubMed PMID: 26709750; PubMed Central PMCID: PMCPmc4943690. .
   PubMed Web of Science ®Google Scholar
• Marjanovic ND, Weinberg RA, Chaffer CL. Poised with purpose: cell plasticity enhances tumorigenicity. Cell Cycle (Georgetown, Tex). 2013;12(17):2713–2714. Epub 2013/ 08/24. PubMed PMID: 23966153; PubMed Central PMCID: PMCPmc3899180. .
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–715. Epub 2008/05/20. PubMed PMID: 18485877; PubMed Central PMCID: PMCPmc2728032. .
   PubMed Web of Science ®Google Scholar
• Gupta PB, Fillmore CM, Jiang G, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 2011;146(4):633–644. Epub 2011/08/23. PubMed PMID: 21854987. .
   PubMed Web of Science ®Google Scholar
• Biddle A, Liang X, Gammon L, et al. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 2011;71(15):5317–5326. Epub 2011/06/21. PubMed PMID: 21685475. .
   PubMed Web of Science ®Google Scholar
• Visvader JE, Clevers H. Tissue-specific designs of stem cell hierarchies. Nat Cell Biol. 2016;18(4):349–355. Epub 2016/03/22. PubMed PMID: 26999737. .
   PubMed Web of Science ®Google Scholar
• Vicente-Duenas C, Hauer J, Cobaleda C, et al. Epigenetic priming in cancer initiation. Trends in Cancer. 2018;4(6):408–417. Epub 2018/06/05. PubMed PMID: 29860985. .
   PubMed Web of Science ®Google Scholar
• Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11(12):1487–1495. Epub 2009/11/26. PubMed PMID: 19935649. .
   PubMed Web of Science ®Google Scholar
• Ye X, Tam WL, Shibue T, et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature. 2015;525(7568):256–260. Epub 2015/09/04. PubMed PMID: 26331542; PubMed Central PMCID: PMCPmc4764075. .
   PubMed Web of Science ®Google Scholar
• Wu YC, Tang SJ, Sun GH, et al. CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer. Oncogene. 2016;35(16):2123–2132. Epub 2015/ 07/28. PubMed PMID: 26212008. .
   PubMed Web of Science ®Google Scholar
• Leung EL, Fiscus RR, Tung JW, et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PloS One. 2010;5(11):e14062. Epub 2010/12/03. PubMed PMID: 21124918; PubMed Central PMCID: PMCPmc2988826. .
   PubMed Web of Science ®Google Scholar
• Brown RL, Reinke LM, Damerow MS, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 2011;121(3):1064–1074. Epub 2011/03/12. PubMed PMID: 21393860; PubMed Central PMCID: PMCPmc3049398. .
   PubMed Web of Science ®Google Scholar
• Xu H, Tian Y, Yuan X, et al. The role of CD44 in epithelial-mesenchymal transition and cancer development. Onco Targets Ther. 2015;8:3783–3792. Epub 2016/ 01/01. PubMed PMID: 26719706; PubMed Central PMCID: PMCPmc4689260. .
   PubMed Web of Science ®Google Scholar
• Preca BT, Bajdak K, Mock K, et al. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. International Journal of Cancer. 2015;137(11):2566–2577. Epub 2015/06/17. PubMed PMID: 26077342. .
   PubMed Web of Science ®Google Scholar
• Godar S, Ince TA, Bell GW, et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell. 2008;134(1):62–73. Epub 2008/07/11. PubMed PMID: 18614011; PubMed Central PMCID: PMCPmc3222460. .
   PubMed Web of Science ®Google Scholar
• Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med;2018. Epub 2018/ 07/26. PubMed PMID: 30043221. DOI:10.1007/s11684-018-0656-6.
   Web of Science ®Google Scholar
• Korpal M, Ell BJ, Buffa FM, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011;17(9):1101–1108. Epub 2011/08/09. PubMed PMID: 21822286; PubMed Central PMCID: PMCPmc3169707. .
   PubMed Web of Science ®Google Scholar
• Ocana OH, Corcoles R, Fabra A, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012;22(6):709–724. Epub 2012/12/04. PubMed PMID: 23201163. .
   PubMed Web of Science ®Google Scholar
• Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012;22(6):725–736. Epub 2012/12/04. PubMed PMID: 23201165; PubMed Central PMCID: PMCPmc3522773. .
   PubMed Web of Science ®Google Scholar
• Skrypek N, Goossens S, De Smedt E, et al. Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity. Trends in Genetics: TIG. 2017;33(12):943–959. Epub 2017/09/19. PubMed PMID: 28919019. .
   PubMed Web of Science ®Google Scholar
• Voon DC, Huang RY, Jackson RA, et al. The EMT spectrum and therapeutic opportunities. Mol Oncol. 2017;11(7):878–891. Epub 2017/05/26. PubMed PMID: 28544151; PubMed Central PMCID: PMCPmc5496500. .
   PubMed Web of Science ®Google Scholar
• Lan X, Jorg DJ, Cavalli FMG, et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. Nature. 2017;549(7671):227–232. Epub 2017/ 08/31. PubMed PMID: 28854171; PubMed Central PMCID: PMCPmc5608080. .
   PubMed Web of Science ®Google Scholar
• Mainardi S, Mijimolle N, Francoz S, et al. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma. Proc Natl Acad Sci U S A. 2014;111(1):255–260. Epub 2013/ 12/25PubMed PMID: 24367082; PubMed Central PMCID: PMCPmc3890787. .
   PubMed Web of Science ®Google Scholar
• Kwon MC, Berns A. Mouse models for lung cancer. Mol Oncol. 2013;7(2):165–177. Epub 2013/03/14. PubMed PMID: 23481268; PubMed Central PMCID: PMCPmc5528410. .
   PubMed Web of Science ®Google Scholar
• Navas C, Hernandez-Porras I, Schuhmacher AJ, et al. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell. 2012;22(3):318–330. Epub 2012/09/15. PubMed PMID: 22975375; PubMed Central PMCID: PMCPmc3601542. .
   PubMed Web of Science ®Google Scholar
• Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nature Reviews Molecular Cell Biology. 2012;13(5):283–296. Epub 2012/04/05. PubMed PMID: 22473468. .
   PubMed Web of Science ®Google Scholar
• Jin G, Kim MJ, Jeon HS, et al. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung cancer. (Amsterdam, Netherlands). 2010;69(3):279–283. Epub 2009/ 12/19. PubMed PMID: 20018398. .
   Google Scholar
• Iwanaga K, Yang Y, Raso MG, et al. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res. 2008;68(4):1119–1127. Epub 2008/02/19. PubMed PMID: 18281487; PubMed Central PMCID: PMCPmc2750029. .
   PubMed Web of Science ®Google Scholar
• Muzumdar MD, Dorans KJ, Chung KM, et al. Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. Nat Commun. 2016;7:12685. Epub 2016/09/03. PubMed PMID: 27585860; PubMed Central PMCID: PMCPmc5025814. .
   PubMed Web of Science ®Google Scholar
• Jackson EL, Olive KP, Tuveson DA, et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 2005;65(22):10280–10288. Epub 2005/11/17. PubMed PMID: 16288016. .
   PubMed Web of Science ®Google Scholar
• Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001;410(6832):1111–1116. Epub 2001/ 04/27. PubMed PMID: 11323676. .
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu X, Huang L, et al. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nat Commun. 2014;5:5660. Epub 2014/12/02. PubMed PMID: 25434817. .
   PubMed Web of Science ®Google Scholar
• Liu Y, Siles L, Lu X, et al. Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells. Nat Commun. 2018;9(1):2424. Epub 2018/06/23. PubMed PMID: 29930325; PubMed Central PMCID: PMCPmc6013470. .
   PubMedGoogle Scholar
• Sutherland KD, Song JY, Kwon MC, et al. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma. Proc Natl Acad Sci U S A. 2014;111(13):4952–4957. Epub 2014/03/04. PubMed PMID: 24586047; PubMed Central PMCID: PMCPmc3977239. .
   PubMed Web of Science ®Google Scholar
• Ahn YH, Gibbons DL, Chakravarti D, et al. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J Clin Invest. 2012;122(9):3170–3183. Epub 2012/08/02. PubMed PMID: 22850877; PubMed Central PMCID: PMCPmc3428095. .
   PubMed Web of Science ®Google Scholar
• Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2(2):103–112. Epub 2002/09/03.PubMedPMID: 12204530.
   PubMed Web of Science ®Google Scholar
• Chiche A, Moumen M, Romagnoli M, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. 2017;36(17):2355–2365. Epub 2016/ 10/25. PubMed PMID: 27775073. .
   PubMed Web of Science ®Google Scholar
• Kastenhuber ER, Lowe SW. Putting p53 in Context. Cell. 2017;170(6):1062–1078. Epub 2017/09/09. PubMed PMID: 28886379. .
   PubMed Web of Science ®Google Scholar
• Knoblich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nature Reviews Molecular Cell Biology. 2010;11(12):849–860. Epub 2010/ 11/26. PubMed PMID: 21102610; PubMed Central PMCID: PMCPmc3941022. .
   PubMed Web of Science ®Google Scholar
• Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell. 2013;154(2):274–284. Epub 2013/07/23. PubMed PMID: 23870119. .
   PubMed Web of Science ®Google Scholar
• Habib SJ, Chen BC, Tsai FC, et al. A localized Wnt signal orients asymmetric stem cell division in vitro. Science (New York, NY). 2013;339(6126):1445–1448. Epub 2013/03/23. PubMed PMID: 23520113; PubMed Central PMCID: PMCPmc3966430. .
   Google Scholar
• Farin HF, Jordens I, Mosa MH, et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature. 2016;530(7590):340–343. Epub 2016/ 02/11. PubMed PMID: 26863187. .
   PubMed Web of Science ®Google Scholar
• Chakrabarti R, Celia-Terrassa T. Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche. 2018;360(6396). PubMed PMID: 29773667. DOI:10.1126/science.aan4153.
   Google Scholar
• Paksa A, Rajagopal J. The epigenetic basis of cellular plasticity. Curr Opin Cell Biol. 2017;49:116–122. Epub 2018/ 02/08. PubMed PMID: 29413970; PubMed Central PMCID: PMCPmc5949887. .
   PubMed Web of Science ®Google Scholar
• Srivastava D, DeWitt N. In vivo cellular reprogramming: the next generation. Cell. 2016;166(6):1386–1396. Epub 2016/ 09/10. PubMed PMID: 27610565.
   PubMed Web of Science ®Google Scholar
• Papp B, Plath K. Epigenetics of reprogramming to induced pluripotency. Cell. 2013;152(6):1324–1343. Epub 2013/03/19. PubMed PMID: 23498940; PubMed Central PMCID: PMCPmc3602907. .
   PubMed Web of Science ®Google Scholar
• Cherry AB, Daley GQ. Reprogramming cellular identity for regenerative medicine. Cell. 2012;148(6):1110–1122. Epub 2012/03/20. PubMed PMID: 22424223; PubMed Central PMCID: PMCPmc3354575. .
   PubMed Web of Science ®Google Scholar
• Rowlands H, Dhavarasa P, Cheng A, et al. Forks on the Run: can the Stalling of DNA Replication Promote Epigenetic Changes? Front Genet. 2017;8:86. Epub 2017/ 07/12. PubMed PMID: 28690636; PubMed Central PMCID: PMCPmc5479891. .
   PubMedGoogle Scholar
• Nakano S, Stillman B, Horvitz HR. Replication-coupled chromatin assembly generates a neuronal bilateral asymmetry in C. elegans. Cell. 2011;147(7):1525–1536. Epub 2011/12/20. PubMed PMID: 22177093; PubMed Central PMCID: PMCPmc3290763. .
   PubMed Web of Science ®Google Scholar
• Xie J, Wooten M, Tran V, et al. Histone H3 threonine phosphorylation regulates asymmetric histone inheritance in the drosophila male germline. Cell. 2015;163(4):920–933. Epub 2015/11/03. PubMed PMID: 26522592; PubMed Central PMCID: PMCPmc4636931. .
   PubMed Web of Science ®Google Scholar
• Xie J, Wooten M, Tran V, et al. Breaking symmetry - asymmetric histone inheritance in stem cells. Trends Cell Biol. 2017;27(7):527–540. Epub 2017/03/08. PubMed PMID: 28268050; PubMed Central PMCID: PMCPmc5476491. .
   PubMed Web of Science ®Google Scholar
• Kahney EW, Ranjan R, Gleason RJ, et al. Symmetry from asymmetry or asymmetry from symmetry? Cold Spring Harb Symp Quant Biol. 2017;82:305–318. Epub 2018/ 01/20. PubMed PMID: 29348326. .
   PubMedGoogle Scholar
• Lin S, Yuan ZF, Han Y, et al. Preferential phosphorylation on old histones during early mitosis in human cells. J Biol Chem. 2016;291(29):15342–15357. Epub 2016/05/27. PubMed PMID: 27226594; PubMed Central PMCID: PMCPmc4946945. .
   PubMed Web of Science ®Google Scholar
• Tajbakhsh S, Gonzalez C. Biased segregation of DNA and centrosomes: moving together or drifting apart? Nature Reviews Molecular Cell Biology. 2009;10(11):804–810. Epub 2009/ 10/24. PubMed PMID: 19851338. .
   PubMed Web of Science ®Google Scholar
• Serresi M, Gargiulo G, Proost N, et al. Polycomb repressive complex 2 is a barrier to kras-driven inflammation and epithelial-mesenchymal transition in non-small-cell lung Cancer. Cancer Cell. 2016;29(1):17–31. Epub 2016/01/15. PubMed PMID: 26766588. .
   PubMed Web of Science ®Google Scholar
• Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6(5):447–458. Epub 2004/11/16. PubMed PMID: 15542429. .
   PubMed Web of Science ®Google Scholar
• Ji H, Houghton AM, Mariani TJ, et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene. 2006;25(14):2105–2112. Epub 2005/ 11/17. PubMed PMID: 16288213. .
   PubMed Web of Science ®Google Scholar
• Imani S, Wei C, Cheng J, et al. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Oncotarget. 2017;8(13):21362–21379. Epub 2017/ 04/21. PubMed PMID: 28423483; PubMed Central PMCID: PMCPmc5400590. .
   PubMedGoogle Scholar
• Bu P, Wang L, Chen KY, et al. A miR-34a-numb feedforward loop triggered by inflammation regulates asymmetric stem cell division in intestine and colon cancer. Cell Stem Cell. 2016;18(2):189–202. Epub 2016/02/06. PubMed PMID: 26849305; PubMed Central PMCID: PMCPmc4751059. .
   PubMed Web of Science ®Google Scholar
• Rocheteau P, Gayraud-Morel B, Siegl-Cachedenier I, et al. A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell. 2012;148(1–2):112–125. Epub 2012/01/24. PubMed PMID: 22265406. .
   PubMed Web of Science ®Google Scholar
• Pine SR, Ryan BM, Varticovski L, et al. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A. 2010;107(5):2195–2200. Epub 2010/01/19. PubMed PMID: 20080668; PubMed Central PMCID: PMCPmc2836660. .
   PubMed Web of Science ®Google Scholar
• Wang F, Dai J, Daum JR, et al. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science (New York, NY). 2010;330(6001):231–235. Epub 2010/08/14. PubMed PMID: 20705812; PubMed Central PMCID: PMCPmc2967368. .
   Google Scholar
• Kelly AE, Ghenoiu C, Xue JZ, et al. Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B. Science (New York, NY). 2010;330(6001):235–239. Epub 2010/08/14. PubMed PMID: 20705815; PubMed Central PMCID: PMCPmc3177562. .
   Google Scholar
• Olcina MM, Foskolou IP, Anbalagan S, et al. Replication stress and chromatin context link ATM activation to a role in DNA replication. Mol Cell. 2013;52(5):758–766. Epub 2013/11/26. PubMed PMID: 24268576; PubMed Central PMCID: PMCPmc3898930. .
   PubMed Web of Science ®Google Scholar